Clinical Impact of New Data on Crohn’s Disease and Ulcerative Colitis

February 16-19, 2022; Virtual
Download these slides for expert insights on key trials presented at ECCO 2022 and the impact the data will have in the management of patients with Crohn disease and ulcerative colitis.
Uma Mahadevan, MD
Bruce E. Sands, MD, MS
Format: Microsoft PowerPoint (.ppt)
File Size: 443 KB
Released: May 6, 2022

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Bristol-Myers Squibb

Related Content

This downloadable infographic resource from Clinical Care Options (CCO) reviews the therapeutic drug monitoring principles in managing anti-TNF agents in IBD

Bruce E. Sands, MD, MS Released: November 7, 2022

On-demand webcast featuring expert discussion of recent advances in systemic lupus erythematosus (SLE) and lupus nephritis, from Clinical Care Options (CCO)

Karen H. Costenbader, MD, MPH Brad H. Rovin, MD Physicians: maximum of 0.75 AMA PRA Category 1 Credits Registered Nurses: 0.75 Nursing contact hours Released: May 25, 2022 Expired: May 24, 2023

On-demand webcast featuring an expert panel with insight on new data presented at ECCO 2022 for Crohn disease and ulcerative colitis from Clinical Care Options (CCO)

Uma Mahadevan, MD Bruce E. Sands, MD, MS Physicians: maximum of 0.75 AMA PRA Category 1 Credits Released: May 19, 2022 Expired: May 18, 2023

Clinical Care Options (CCO) presents expert commentary on new data in Crohn disease and ulcerative colitis from ECCO 2022

Bruce E. Sands, MD, MS Released: May 13, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings